curaleaf

Multistate marijuana company Curaleaf posts higher revenues, losses

Curaleaf Holdings, a multistate cannabis operator, reported revenue of $48.5 million in the second quarter, more than triple the $14.6 million in revenue during the same period of 2018. The Massachusetts-based company lost $24.4 million in the quarter, ending June 30, mostly due to noncash items and one-time, acquisition-related charges. That’s compared with a loss […]

Read More

Curaleaf fined $250K for Massachusetts marijuana ownership snafu

Massachusetts-based Curaleaf was fined $250,000 for failing to disclose a change of ownership structure related to its cannabis operations in the state. The fine relates to Curaleaf Massachusetts changing its status from not-for-profit to for-profit but not detailing additional changes as parent company Curaleaf started trading on the Canadian Securities Exchange (CSE), according to MassLive.com. […]

Read More

Antitrust issues weigh on US cannabis stocks, but is it enough to unravel deals?

The U.S. cannabis industry has seen billions of dollars of acquisitions in recent months, attracting scrutiny from federal trustbusters examining whether planned purchases could quash competition in the emerging marijuana industry. The U.S. Department of Justice’s review of the deals – including those involving Chicago-based Cresco Labs (CSE: CL; OTC: CRLBF) and Arizona-based Harvest Health & Recreation (CSE: HARV; OTC: […]

Read More

Curaleaf agrees to acquire marijuana giant Grassroots for $875 million

Massachusetts-based Curaleaf, a cannabis company with a market cap of about $3.6 billion, on Wednesday agreed to buy privately owned Grassroots Cannabis for $875 million in stock and cash. Curaleaf said the transaction – $75 million of it is in cash, the rest in stock – “solidifies” its position as the world’s largest marijuana company in […]

Read More

Curaleaf Q1 marijuana revenue climbs to $35.3 million

Curaleaf, a Massachusetts-based, vertically integrated cannabis company, reported first-quarter revenue of $35.3 million, up from $9.1 million for the same period in 2018. Net loss for the company in the period totaled $10.8 million versus $3.4 million last year. Curaleaf, which agreed to acquire Cura Partners in a nearly $1 billion deal earlier this month, […]

Read More

Florida medical marijuana operators file complaints to get more storefronts

The second- and third-largest medical cannabis operators in Florida filed complaints seeking the same treatment as Trulieve, a vertically integrated MMJ business that the state permitted to open 14 more dispensaries over the current state cap of 35. The complaints by Curaleaf and Surterra Wellness, which allege that Trulieve has an unfair competitive advantage, are scheduled […]

Read More

Chart: Florida medical cannabis market surges ahead, with five companies dominating

Florida’s medical marijuana market is booming, with an average of nearly two dispensaries opening each week across the state. The number of enrolled patients recently zipped past the 200,000 mark with more than 10,000 new patients signing up each week. But despite numbers that make the Sunshine State among the fastest-growing MMJ markets in the […]

Read More

Multistate marijuana firm Curaleaf to expand into Ohio with $20 million acquisition

Massachusetts-based Curaleaf, which last week agreed to acquire Cura Partners for almost $1 billion, will expand into Ohio with the purchase of Ohio Grown Therapies. The $20 million deal, expected to close in the second half of 2019, includes the acquisition of Johnstown-based Ohio Grown Therapies’ cultivation and processing facilities and licenses. For more details, click […]

Read More

Cannabis group Curaleaf to acquire Cura Partners for CA$1.27 billion

Massachusetts-based Curaleaf, a vertically integrated cannabis company, agreed to acquire Portland, Oregon-based Cura Partners in an all-stock deal worth 1.27 billion Canadian dollars ($949 million). Curaleaf will issue 95.6 million subordinated voting shares, giving Cura a roughly 16% stake in the company. The deal is the latest in a string of recent mega-deals in the cannabis […]

Read More

BlackRock discloses $11M investment in medical marijuana firm Curaleaf

BlackRock, one of the world’s largest money managers, disclosed in regulatory filings that its funds have an $11 million stake in Curaleaf Holdings, a Massachusetts-based medical cannabis company. While the investment is tiny for BlackRock, which has nearly $6 trillion of assets under management, the stake is one of the first publicly disclosed investments by a […]

Read More

Marijuana company Curaleaf to buy Nevada’s Acres Cannabis for $70M

Massachusetts-based Curaleaf, a vertically integrated cannabis operator, agreed to buy Acres Cannabis for $70 million in a cash and stock deal. Acres Cannabis currently operates 269,000 square feet of cultivation facilities in Nevada with plans to expand that to more than 400,000 square feet. The company also has a flagship dispensary in Las Vegas and […]

Read More